These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20413309)

  • 1. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009.
    Benveniste O; Hilton-Jones D
    Neuromuscul Disord; 2010 Jun; 20(6):414-21. PubMed ID: 20413309
    [No Abstract]   [Full Text] [Related]  

  • 2. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches.
    Needham M; Mastaglia FL
    Lancet Neurol; 2007 Jul; 6(7):620-31. PubMed ID: 17582362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current status of treatment for inclusion-body myositis.
    Griggs RC
    Neurology; 2006 Jan; 66(2 Suppl 1):S30-2. PubMed ID: 16432142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands.
    Hoogendijk JE; Amato AA; Lecky BR; Choy EH; Lundberg IE; Rose MR; Vencovsky J; de Visser M; Hughes RA
    Neuromuscul Disord; 2004 May; 14(5):337-45. PubMed ID: 15099594
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome measures in the idiopathic inflammatory myopathies: On the search for the holy grail.
    Dimachkie MM; Paganoni S
    Neurology; 2017 Jul; 89(1):20-21. PubMed ID: 28566551
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis and therapy of inclusion body myositis.
    Greenberg SA
    Curr Opin Neurol; 2012 Oct; 25(5):630-9. PubMed ID: 22941263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Idiopathic myositis].
    Burgunder JM
    Ther Umsch; 2003 Jul; 60(7):407-12. PubMed ID: 12956034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular tachycardia in a patient with inclusion-body myositis.
    Prutkin JM; Patton KK
    Pacing Clin Electrophysiol; 2009 Dec; 32(12):e36-9. PubMed ID: 19744271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 188th ENMC International Workshop: Inclusion Body Myositis, 2-4 December 2011, Naarden, The Netherlands.
    Rose MR;
    Neuromuscul Disord; 2013 Dec; 23(12):1044-55. PubMed ID: 24268584
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inclusion-body myositis].
    Benveniste O
    Rev Med Interne; 2014 Jul; 35(7):472-9. PubMed ID: 24128435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion body myositis and myopathies.
    Griggs RC; Askanas V; DiMauro S; Engel A; Karpati G; Mendell JR; Rowland LP
    Ann Neurol; 1995 Nov; 38(5):705-13. PubMed ID: 7486861
    [No Abstract]   [Full Text] [Related]  

  • 12. Inclusion body myositis and sarcoid myopathy: coincidental occurrence or associated diseases.
    Sanmaneechai O; Swenson A; Gerke AK; Moore SA; Shy ME
    Neuromuscul Disord; 2015 Apr; 25(4):297-300. PubMed ID: 25599912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The etiology and pathogenesis of sporadic inclusion body myositis].
    Murata KY; Ito H
    Brain Nerve; 2014 Nov; 66(11):1385-94. PubMed ID: 25407074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term observational study of sporadic inclusion body myositis.
    Benveniste O; Guiguet M; Freebody J; Dubourg O; Squier W; Maisonobe T; Stojkovic T; Leite MI; Allenbach Y; Herson S; Brady S; Eymard B; Hilton-Jones D
    Brain; 2011 Nov; 134(Pt 11):3176-84. PubMed ID: 21994327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: quantitative assessment of inflammation and β-amyloid in the muscle.
    Zschüntzsch J; Voss J; Creus K; Sehmisch S; Raju R; Dalakas MC; Schmidt J
    Arthritis Rheum; 2012 Dec; 64(12):4094-103. PubMed ID: 22941914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of inclusion body myositis: autoimmune or degenerative disease?].
    Uruha A; Nishino I
    Brain Nerve; 2013 Nov; 65(11):1291-8. PubMed ID: 24200607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion Body Myositis.
    Greenberg SA
    Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1871-1888. PubMed ID: 27922498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 215th ENMC International Workshop VCP-related multi-system proteinopathy (IBMPFD) 13-15 November 2015, Heemskerk, The Netherlands.
    Evangelista T; Weihl CC; Kimonis V; Lochmüller H;
    Neuromuscul Disord; 2016 Aug; 26(8):535-47. PubMed ID: 27312024
    [No Abstract]   [Full Text] [Related]  

  • 19. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1β-induced accumulation of β-amyloid and cell death.
    Schmidt J; Barthel K; Zschüntzsch J; Muth IE; Swindle EJ; Hombach A; Sehmisch S; Wrede A; Lühder F; Gold R; Dalakas MC
    Brain; 2012 Apr; 135(Pt 4):1102-14. PubMed ID: 22436237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous immunoglobulin treatment of inclusion-body myositis stabilizes dysphagia.
    Pars K; Garde N; Skripuletz T; Pul R; Dengler R; Stangel M
    Muscle Nerve; 2013 Nov; 48(5):838-9. PubMed ID: 23649689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.